Paul J. Schmitt

Chrysalis International Corp. provides drug development services to the pharmaceutical and biotechnology industries. Its services include transgenic discovery research, preclinical development and clinical capabilities. The company was founded in 1988 and is headquartered in Raritan, NJ.

Amorcyte, Inc. provides cell therapy product development services. It focuses on developing cell therapeutics for cardiovascular disease. The company was founded by Andrew L. Pecora in 2004 and is headquartered in Allendale, NJ.

BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart.

The Wistar Institute provides biomedical research services. It researches on diseases such as cancer, cardiovascular, autoimmune disorders and infectious diseases and develops vaccine. The company was founded in 1892 and is headquartered in Philadelphia, PA

Cernostics, Inc. develops and commercializes cancer diagnostic tests. Its technology is based on a systems approach to evaluating tissues via anatomic pathology and simultaneously evaluates immune, stromal, stem cell and tumor biomarkers on a single slide while preserving tissue structure. The company was founded in 2008 by Michel Nederlof and Rebecca Critchley-Thorne and is headquartered in Pittsburgh, PA.

Logical Therapeutics, Inc. develops products that treat diseases associated with inflammation. It provides a platform of bio-activated prodrugs for the chronic treatment of arthritis. Its bio-activated NSAID prodrugs are chemical entities that are designed to reduce the incidence of GI ulcers and improve GI tolerability in patients who require chronic NSAID treatment. The company was founded by Carolyn E. Green in 2005 and is headquartered in Waltham, MA.

Novitas Capital III LP seeks investment opportunities in companies located in the Mid-Atlantic region with a primary focus on Pennsylvania (US). The fund targets companies operating in the fields of technology and life science. It acts as a lead and co-lead investor for start-up and early stage capital requirements. Its initial investment size ranges from $0.1 to $2 million and invests up to $6 million over the lifetime of a portfolio investment.

Penn State Research Foundation provides scientific research services aimed at improving human conditions. The non-profit company is based in University Park, PA.

Part of General Electric Co., Datex-Ohmeda, Inc. develops and manufactures medical equipment. The company is based in Madison, WI.

Bellrock Intelligence, Inc. operates as a healthcare information technology company. The firm offers business information management services, advanced analytics capabilities, and security and integration. The company was founded by Robert P. Rittereiser in 2007 and is headquartered in Wayne, PA.